Cervical cancer, version 2.2015: Featured updates to the NCCN guidelines featured updates to the NCCN guidelines Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Practice Guidelines as Topic
  • Uterine Cervical Neoplasms

abstract

  • The NCCN Guidelines for Cervical Cancer provide interdisciplinary recommendations for treating cervical cancer. These NCCN Guidelines Insights summarize the NCCN Cervical Cancer Panel's discussion and major guideline updates from 2014 and 2015. The recommended systemic therapy options for recurrent and metastatic cervical cancer were amended upon panel review of new survival data and the FDA's approval of bevacizumab for treating late-stage cervical cancer. This article outlines relevant data and provides insight into panel decisions regarding various combination regimens. Additionally, a new section was added to provide additional guidance on key principles of evaluation and surgical staging in cervical cancer. This article highlights 2 areas of active investigation and debate from this new section: sentinel lymph node mapping and fertility-sparing treatment approaches.

publication date

  • January 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 25870376

Additional Document Info

start page

  • 395

end page

  • 404; quiz 404

volume

  • 13

number

  • 4